# Cagent Vascular funding: rounds and investors > Cagent Vascular has raised $68M across 3 rounds since 2018. Investors include Trinity Capital, Ben Franklin Technology Partners of Southeastern Pennsylvania... Source: https://millionrounds.com/company/cagent-vascular (Millionrounds; every figure on the page links to its filing or article) United States · [Series C startup](https://millionrounds.com/companies) # Who invested in *Cagent Vascular* 3 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Healthcare Medical Devices Raised 5 months ago Funding summary Updated 26 Oct 2026 **$68M** raised across 3 rounds since 2018, from 4 sources **$12M** Series B **$15M** Venture **$41M** Series C - **Latest round:** Series C, $41M May 2026 - **Step-up i:** 2.7× - **Investors:** 5 See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2018 2020 2022 2024 2026 **$12M** Series B **$15M** Venture **$41M** Series C - **First round:** Series B, $12M - **Biggest round:** $41M - **Usual gap between rounds:** 6.6 years ## The rounds - **May 2026** Series C **$41M** *2 returning* [Trinity Capital](https://millionrounds.com/fund/trinity-capital) [Ben Franklin Technology Partners of Southeastern Pennsylvania](https://millionrounds.com/fund/ben-franklin-techn) Reported by U.S. Venture Partners and 1 other SEC filing: $24M sold - **Feb 2025** Venture **$15M** *2 new* [Trinity Capital](https://millionrounds.com/fund/trinity-capital) [Ben Franklin Technology Partners of Southeastern Pennsylvania](https://millionrounds.com/fund/ben-franklin-techn) Source recorded - **Jul 2018** Series B **$12M** *3 new* [Ben Franklin Technology Partners](https://millionrounds.com/fund/ben-franklin-technology-partners) [Balestier](https://millionrounds.com/fund/balestier) [Synergy](https://millionrounds.com/fund/synergy) Reported by FinSMEs SEC filing: $3.0M sold, first sale Jul 2017 ## Founders and team From Cagent Vascular's own website: 1 founder, 6 on the team. **Robert Giasolli** VP Clinical Engineering & Chief Technology Officer, Co-Founder - **Brian Walsh** Chairman & CEO - **Peter Johansson** Chief Quality & Compliance Officer, VP Engineering - **Aaron Green** Chief Financial Officer - **Paul Wilson** Chief Commercial Officer - **Jonathan Ice** VP of Sales, West - **William Hankins** VP of Sales, East ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Series B** 2018 **Venture** 2025 **Series C** 2026 [Trinity Capital](https://millionrounds.com/fund/trinity-capital) [Ben Franklin Technology Partners of Southeastern Pennsylvania](https://millionrounds.com/fund/ben-franklin-techn) [Ben Franklin Technology Partners](https://millionrounds.com/fund/ben-franklin-technology-partners) [Balestier](https://millionrounds.com/fund/balestier) [Synergy](https://millionrounds.com/fund/synergy) ## Everyone who backed them [Trinity Capital](https://millionrounds.com/fund/trinity-capital) VC firm **2** rounds [Ben Franklin Technology Partners of Southeastern Pennsylvania](https://millionrounds.com/fund/ben-franklin-techn) Government **2** rounds [Ben Franklin Technology Partners](https://millionrounds.com/fund/ben-franklin-technology-partners) Government **1** round [Balestier](https://millionrounds.com/fund/balestier) VC firm **1** round [Synergy](https://millionrounds.com/fund/synergy) Hedge fund **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=cagent-vascular). ## Also claim to have backed them This firm lists Cagent Vascular as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above. [BF Belmont](https://millionrounds.com/fund/bf-belmont) Family office Per its own site ## Quick answers about Cagent Vascular ### Who invested in Cagent Vascular? Cagent Vascular's investors include Trinity Capital, Ben Franklin Technology Partners of Southeastern Pennsylvania, Ben Franklin Technology Partners, Balestier and Synergy. ### How much has Cagent Vascular raised? Cagent Vascular has raised $68M across 3 rounds since 2018. ### When did Cagent Vascular last raise? Cagent Vascular's most recent round was a Series C of $41M in May 2026. ### What was Cagent Vascular's biggest round? Its most recent round, $41M in May 2026, is also its largest on record. ### Who backed Cagent Vascular first? Cagent Vascular's first round on record, in Jul 2018, was backed by Ben Franklin Technology Partners, Balestier and Synergy. ### What stage is Cagent Vascular at? Cagent Vascular's latest named round is a Series C, in May 2026. ### Where is Cagent Vascular based? Cagent Vascular is based in the United States. ## Companies like Cagent Vascular In the same sector, and raised in the last eighteen months. [**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**AI** $18M · Oct 2026](https://millionrounds.com/company/ai)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio)[**Baba** $40M · Oct 2026](https://millionrounds.com/company/baba) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app